Clinical Trial Update: Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 single-dose study of Vitamin E delta-tocotrienol (VEDT) in healthy subjects. The listing notes pancreatic cancer as the associated condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Vitamin E delta-Tocotrienol (VEDT) (delta-tocotrienol)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED